長期投資家のためのIR情報
バリュートレンド

【8138】三京化成
化学品商社。
類似企業:
【業界1位】 長瀬産業
【売上同水準】 ソマール 昭栄薬品


東証スタンダード
卸売
化卸
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2025.03 2024/11/06 Q2予 27,200 0.0% 0.0% 410 0.0% 0.0% 530 0.0% 0.0% 360 0.0% 0.0%
2025.03 2024/08/07 Q1予 27,200 0.0% 0.0% 410 0.0% 0.0% 530 0.0% 0.0% 360 0.0% 0.0%
2025.03 2024/05/10 当初予 27,200 - - - 410 - - - 530 - - - 360 - - -
2024.03 2024/05/10 26,227 -1.0% -6.3% 382 +27.3% -13.2% 502 +22.4% -7.0% 346 +33.1% -1.1%
2024.03 2024/02/05 Q3予 26,500 0.0% -5.4% 300 0.0% -31.8% 410 0.0% -24.1% 260 0.0% -25.7%
2024.03 2023/11/06 Q2予 26,500 -5.4% -5.4% 300 -31.8% -31.8% 410 -24.1% -24.1% 260 -25.7% -25.7%
2024.03 2023/08/04 Q1予 28,000 0.0% 0.0% 440 0.0% 0.0% 540 0.0% 0.0% 350 0.0% 0.0%
2024.03 2023/05/10 当初予 28,000 - - - 440 - - - 540 - - - 350 - - -
2023.03 2023/05/10 26,738 +2.8% +6.5% 340 +21.4% +36.0% 471 +14.9% +34.6% 303 +26.2% +51.5%
2023.03 2023/02/03 Q3予 26,000 0.0% +3.6% 280 0.0% +12.0% 410 0.0% +17.1% 240 0.0% +20.0%
2023.03 2022/11/04 Q2予 26,000 +3.6% +3.6% 280 +12.0% +12.0% 410 +17.1% +17.1% 240 +20.0% +20.0%
2023.03 2022/08/05 Q1予 25,100 0.0% 0.0% 250 0.0% 0.0% 350 0.0% 0.0% 200 0.0% 0.0%
2023.03 2022/05/11 当初予 25,100 - - - 250 - - - 350 - - - 200 - - -
2022.03 2022/05/11 24,239 +8.2% +7.3% 187 +55.8% +133.8% 319 -0.3% +87.6% 62 -74.2% -31.1%
2022.03 2022/02/04 修正予 22,400 -2.6% -0.9% - - - - 320 +39.1% +88.2% 240 +100.0% +166.7%
2022.03 2021/11/05 Q2予 23,000 +1.8% +1.8% 120 +50.0% +50.0% 230 +35.3% +35.3% 120 +33.3% +33.3%
2022.03 2021/08/05 Q1予 22,600 0.0% 0.0% 80 0.0% 0.0% 170 0.0% 0.0% 90 0.0% 0.0%
2022.03 2021/05/12 当初予 22,600 - - - 80 - - - 170 - - - 90 - - -
2021.03 2021/05/12 21,613 -3.1% -3.1% 58 +480.0% +480.0% 183 +66.4% +66.4% 76 - -
2021.03 2021/02/03 Q3予 22,300 0.0% 0.0% 10 0.0% 0.0% 110 0.0% 0.0% 0 - -
2021.03 2020/11/05 Q2予 22,300 0.0% 0.0% 10 0.0% 0.0% 110 0.0% 0.0% 0 - -
2021.03 2020/08/05 当初予 22,300 - - - 10 - - - 110 - - - 0 - - -
2020.03 2020/05/11 24,356 -1.0% -3.3% 59 -26.2% -78.1% 167 -7.2% -53.6% 7 -88.3% -96.8%
2020.03 2020/02/03 Q3予 24,600 -1.6% -2.4% 80 -55.6% -70.4% 180 -35.7% -50.0% 60 -57.1% -72.7%
2020.03 2019/11/05 Q2予 25,000 -0.8% -0.8% 180 -33.3% -33.3% 280 -22.2% -22.2% 140 -36.4% -36.4%
2020.03 2019/08/05 Q1予 25,200 0.0% 0.0% 270 0.0% 0.0% 360 0.0% 0.0% 220 0.0% 0.0%
2020.03 2019/05/09 当初予 25,200 - - - 270 - - - 360 - - - 220 - - -
2019.03 2019/05/09 23,826 +3.6% +3.6% 249 -7.8% -7.8% 351 -2.5% -2.5% 340 -2.9% -2.9%
2019.03 2019/02/01 Q3予 23,000 0.0% 0.0% 270 0.0% 0.0% 360 0.0% 0.0% 350 0.0% 0.0%
2019.03 2018/11/01 Q2予 23,000 0.0% 0.0% 270 0.0% 0.0% 360 0.0% 0.0% 350 0.0% 0.0%
2019.03 2018/07/27 Q1予 23,000 - - - 270 - - - 360 - - - 350 - - -
2018.03 2018/02/01 Q3予 22,900 0.0% 0.0% 310 0.0% 0.0% 400 0.0% 0.0% 320 0.0% 0.0%
2018.03 2017/11/02 Q2予 22,900 0.0% 0.0% 310 0.0% 0.0% 400 0.0% 0.0% 320 0.0% 0.0%
2018.03 2017/08/01 Q1予 22,900 0.0% 0.0% 310 0.0% 0.0% 400 0.0% 0.0% 320 0.0% 0.0%
2018.03 2017/05/11 当初予 22,900 - - - 310 - - - 400 - - - 320 - - -
2017.03 2017/05/11 22,148 +0.7% +0.7% 272 -12.3% -12.3% 364 -4.2% -4.2% 241 -7.3% -7.3%
2017.03 2017/02/01 Q3予 22,000 0.0% 0.0% 310 0.0% 0.0% 380 0.0% 0.0% 260 0.0% 0.0%
2017.03 2016/08/01 Q1予 22,000 - - - 310 - - - 380 - - - 260 - - -
2016.03 2016/02/01 Q3予 22,100 0.0% 0.0% 370 0.0% 0.0% 450 0.0% 0.0% 280 0.0% 0.0%
2016.03 2015/11/02 Q2予 22,100 0.0% 0.0% 370 0.0% 0.0% 450 0.0% 0.0% 280 0.0% 0.0%
2016.03 2015/08/03 Q1予 22,100 - - - 370 - - - 450 - - - 280 - - -
2015.03 2015/02/02 Q3予 21,300 0.0% -4.5% 320 0.0% -25.6% 390 0.0% -22.0% 140 0.0% -54.8%
2015.03 2014/10/31 Q2予 21,300 0.0% -4.5% 320 0.0% -25.6% 390 0.0% -22.0% 140 0.0% -54.8%
2015.03 2014/10/24 修正予 21,300 -4.5% -4.5% 320 -15.8% -25.6% 390 -15.2% -22.0% 140 -30.0% -54.8%
2015.03 2014/07/30 修正予 22,300 0.0% 0.0% 380 -11.6% -11.6% 460 -8.0% -8.0% 200 -35.5% -35.5%
2015.03 2014/05/09 当初予 22,300 - - - 430 - - - 500 - - - 310 - - -
2014.03 2014/05/09 21,387 0.0% 0.0% 405 0.0% 0.0% 582 0.0% 0.0% -10 0.0% 0.0%
2014.03 2014/04/28 当初予 21,387 - - - 405 - - - 582 - - - -10 - - -
ページトップへ戻る